JP2001506606A5 - - Google Patents

Download PDF

Info

Publication number
JP2001506606A5
JP2001506606A5 JP1998524829A JP52482998A JP2001506606A5 JP 2001506606 A5 JP2001506606 A5 JP 2001506606A5 JP 1998524829 A JP1998524829 A JP 1998524829A JP 52482998 A JP52482998 A JP 52482998A JP 2001506606 A5 JP2001506606 A5 JP 2001506606A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998524829A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001506606A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/021649 external-priority patent/WO1998023565A2/en
Publication of JP2001506606A publication Critical patent/JP2001506606A/ja
Publication of JP2001506606A5 publication Critical patent/JP2001506606A5/ja
Ceased legal-status Critical Current

Links

JP52482998A 1996-11-26 1997-11-26 プロテアーゼインヒビターとしてのアミノグアニジンおよびアルコキシグアニジン Ceased JP2001506606A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3182296P 1996-11-26 1996-11-26
US60/031,822 1996-11-26
PCT/US1997/021649 WO1998023565A2 (en) 1996-11-26 1997-11-26 Aminoguanidines and alkoxyguanidines as protease inhibitors

Publications (2)

Publication Number Publication Date
JP2001506606A JP2001506606A (ja) 2001-05-22
JP2001506606A5 true JP2001506606A5 (https=) 2005-08-11

Family

ID=21861593

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52482998A Ceased JP2001506606A (ja) 1996-11-26 1997-11-26 プロテアーゼインヒビターとしてのアミノグアニジンおよびアルコキシグアニジン

Country Status (24)

Country Link
US (5) US6235778B1 (https=)
EP (1) EP0944590B1 (https=)
JP (1) JP2001506606A (https=)
KR (1) KR100587546B1 (https=)
CN (1) CN1237961A (https=)
AR (1) AR008327A1 (https=)
AT (1) ATE214693T1 (https=)
AU (1) AU725058B2 (https=)
BR (1) BR9713328A (https=)
CA (1) CA2273023C (https=)
DE (1) DE69711222T2 (https=)
DK (1) DK0944590T3 (https=)
EA (1) EA002740B1 (https=)
ES (1) ES2174309T3 (https=)
HU (1) HUP0000733A3 (https=)
IL (1) IL130102A (https=)
IN (1) IN190530B (https=)
NO (1) NO314140B1 (https=)
NZ (1) NZ336093A (https=)
PL (1) PL333434A1 (https=)
PT (1) PT944590E (https=)
TW (1) TW499412B (https=)
WO (1) WO1998023565A2 (https=)
ZA (1) ZA9710646B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999026926A1 (en) 1997-11-26 1999-06-03 3-Dimensional Pharmaceuticals, Inc. Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
US6344486B1 (en) 1998-04-03 2002-02-05 3-Dimensional Pharmaceuticals, Inc. Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
AU750561B2 (en) 1998-04-24 2002-07-25 3-Dimensional Pharmaceuticals, Inc. Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
NZ508669A (en) 1998-06-11 2003-06-30 Dimensional Pharm Inc Pyrazinone protease inhibitors
AU3731400A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
US6544541B1 (en) * 1999-06-02 2003-04-08 Cardiovascular Solutions, Inc. Devices and compounds for treating arterial restenosis
US6476016B2 (en) 2000-07-17 2002-11-05 3-Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine pyrazinones as protease inhibitors
MXPA03000963A (es) 2000-08-04 2004-04-05 Dimensional Pharm Inc Inhibidores de oxiguanidina ciclica proteasa.
KR100371008B1 (ko) * 2000-08-05 2003-02-06 조동련 혈소판 응집 억제제 부착 스텐트의 그 제조 방법
UA75093C2 (en) 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
CA2455951A1 (en) * 2001-08-03 2003-02-20 The Board Of Trustees Of The Leland Stanford Junior University Bi-directional synthesis of oligoguanidine transport agents
US20060264608A1 (en) * 2001-08-03 2006-11-23 Wender Paul A Bi-directional synthesis of oligoguanidine transport agents
JP4496407B2 (ja) * 2002-05-13 2010-07-07 ベクトン・ディキンソン・アンド・カンパニー プロテアーゼ阻害剤試料採取システム
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
CN101213172A (zh) * 2005-06-30 2008-07-02 拜尔农作物科学股份公司 具有杀虫作用的(二取代丙烯基)苯基烷基取代的杂环类化合物的改良的制备方法
EP1971336A2 (en) * 2005-12-22 2008-09-24 Shering Corporation Thrombin receptor antagonists as phophylaxis to complications from cardiopulmonary surgery
ES2405655T3 (es) 2006-12-26 2013-05-31 Lantheus Medical Imaging, Inc. N-[3-bromo-4-(3-[18F]fluoropropoxi)-bencil]-guanidina para la formación de imágenes de la inervación cardíaca
EP2434290B1 (en) * 2009-05-20 2016-02-10 Sekisui Medical Co., Ltd. Blood coagulation time prolonging agent
ES2763815T3 (es) 2010-05-11 2020-06-01 Lantheus Medical Imaging Inc Composiciones, métodos y sistemas para la síntesis y uso de agentes de formación de imágenes
CA2824599C (en) * 2010-12-31 2020-03-10 Astrazeneca Uk Limited Arginase inhibitors and methods of use thereof
WO2012158983A2 (en) 2011-05-17 2012-11-22 Qiyong Peter Liu Improved platelet storage using a sialidase inhibitor
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
CN102850451B (zh) * 2011-06-29 2014-05-07 辽宁诺康生物制药有限责任公司 具有抑制纤溶酶活性的重组textilinin-1及其制备方法和应用
CA3194125A1 (en) 2012-04-12 2013-10-17 The Trustees Of The University Of Pennsylvania Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
EP2903430A1 (en) 2012-10-05 2015-08-12 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
WO2014120886A1 (en) 2013-01-30 2014-08-07 Velico Medical, Inc. Platelet additive solution having a self-assembling hydrogel-forming peptide
US9555016B2 (en) 2013-06-10 2017-01-31 Covidien Lp Lytic agents for use in treating intravascular clots
CN107382869A (zh) * 2017-08-01 2017-11-24 李凯 一种治疗中风后遗症的化合物及制备方法和应用
GB2568550B (en) * 2017-11-21 2021-06-30 Univ Cape Town Method of synthesising 6-deoxy-6-amino-ß-d-glucopyranoside-containing polymers
EP4183777A4 (en) * 2020-07-20 2023-11-29 Shenzhen Mindray Bio-Medical Electronics Co., Ltd USE OF A PLATELET DISAGGREGATION COMPOSITION, DISAGGREGATION REAGENT AND DISAGGREGATION METHOD
GB202108544D0 (en) * 2021-06-15 2021-07-28 Z Factor Ltd Compounds and their use for the treatment of alpha1-antitrypsin deficiency
CN115772196A (zh) * 2021-09-08 2023-03-10 赛诺哈勃药业(成都)有限公司 一种纤溶酶抑制活性的化合物、其制备方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131218A (en) * 1961-02-15 1964-04-28 Smith Kline French Lab N-amino guanidine derivatives
US3271448A (en) 1961-11-21 1966-09-06 Pfizer & Co C Phenoxyalkyl aminoguanidines
BE663481A (https=) 1964-05-05
US3413303A (en) * 1965-09-27 1968-11-26 Ciba Geigy Corp Aralkenyloxyguanidines
JPS57178739A (en) 1981-04-27 1982-11-04 Mitsubishi Heavy Ind Ltd Bead supplying device for tire molding machine
US4429146A (en) * 1982-04-15 1984-01-31 Gaf Corporation Substituted diphenyl ether herbicides and process for use
JPS6229566A (ja) 1985-07-30 1987-02-07 Taiyo Yakuhin Kogyo Kk 新規グアニジノメチル安息香酸誘導体
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
EP0604022A1 (en) 1992-12-22 1994-06-29 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method for its manufacture
TW257757B (https=) 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
GB9318637D0 (en) 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
US6087479A (en) 1993-09-17 2000-07-11 Nitromed, Inc. Localized use of nitric oxide-adducts to prevent internal tissue damage
US5466811A (en) 1994-07-18 1995-11-14 Merck & Co., Inc. Dioxolenylmethyl carbamates pro moieties for amine drugs
US5643580A (en) 1994-10-17 1997-07-01 Surface Genesis, Inc. Biocompatible coating, medical device using the same and methods
AU699821B2 (en) 1994-10-17 1998-12-17 Kabushikikaisha Igaki Iryo Sekkei Stent for liberating drug
US5637113A (en) 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
DE19514104C2 (de) 1995-04-13 1997-05-28 Behringwerke Ag Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial
HU211262A9 (hu) 1995-05-12 1995-11-28 Hoechst Ag Benzoil-guanidinek
US5792769A (en) 1995-09-29 1998-08-11 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
CA2233344A1 (en) 1995-09-29 1997-04-03 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
GB9525620D0 (en) 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds
EP0883405B1 (en) 1995-12-29 2004-02-25 3-Dimensional Pharmaceuticals, Inc. Amidino protease inhibitors
CA2250426C (en) 1996-03-29 2006-05-02 3-Dimensional Pharmaceuticals, Inc. Amidinohydrazones as protease inhibitors
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000501771A5 (https=)
JP2000501599A5 (https=)
JP2000501018A5 (https=)
JP2002510439A5 (https=)
JP2000500076A5 (https=)
JP2001512329A5 (https=)
JP2000501324A5 (https=)
JP2000500026A5 (https=)
JP2000502472A5 (https=)
JP2000501825A5 (https=)
JP2000501338A5 (https=)
JP2000500874A5 (https=)
JP2000502425A5 (https=)
JP2000502485A5 (https=)
JP2000502568A5 (https=)
JP2000501774A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2000501876A5 (https=)
JP2000501744A5 (https=)
JP2000501229A5 (https=)
JP2000502316A5 (https=)
JP2000500857A5 (https=)
JP2000502714A5 (https=)